Potent antitumor activity of cabozantinib, a c-MET and VEGFR2 inhibitor, in a colorectal cancer patient-derived tumor explant model

  • Eun Kee Song
  • , W. M. Tai
  • , Wells A. Messersmith
  • , Stacey Bagby
  • , Alicia Purkey
  • , Kevin S. Quackenbush
  • , Todd M. Pitts
  • , Guoliang Wang
  • , Patrick Blatchford
  • , Rachel Yahn
  • , Jeffrey Kaplan
  • , Aik Choon Tan
  • , Chloe E. Atreya
  • , Gail Eckhardt
  • , Robin K. Kelley
  • , Alan Venook
  • , Eunice L. Kwak
  • , David Ryan
  • , John J. Arcaroli*
    • *Corresponding author for this work

    Research output: Contribution to journal › Article › peer-review

    53 Citations (Scopus)

    Fingerprint

    Dive into the research topics of 'Potent antitumor activity of cabozantinib, a c-MET and VEGFR2 inhibitor, in a colorectal cancer patient-derived tumor explant model'. Together they form a unique fingerprint.

    Keyphrases

    Pharmacology, Toxicology and Pharmaceutical Science